Correction to: Effect of CYP3A Inhibition and Induction on the Pharmacokinetics of Suvorexant: Two Phase I, Open-Label, Fixed-Sequence Trials in Healthy Subjects

被引：0
|
作者：
Rebecca E. Wrishko
Jacqueline B. McCrea
Ka Lai Yee
Wen Liu
Deborah Panebianco
Eric Mangin
Manu Chakravarthy
Maria P. Martinez-Cantarin
Walter K. Kraft
机构：
[1] Merck & Co.,Department of Pharmacology and Experimental Therapeutics
[2] Inc.,undefined
[3] Thomas Jefferson University,undefined
来源：
Clinical Drug Investigation | 2019年 / 39卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The original version of this article unfortunately contained a mistake
引用
收藏
页码：453 / 454
页数：1
相关论文
共 50 条
  • [41] Correction to: The Effect of Rifampin on the Pharmacokinetics and Safety of Lorlatinib: Results of a Phase One, Open-Label, Crossover Study in Healthy Participants
    Joseph Chen
    Huiping Xu
    Sylvester Pawlak
    Leonard P. James
    Gerson Peltz
    Kimberly Lee
    Katherine Ginman
    Michelle Bergeron
    Yazdi K. Pithavala
    Advances in Therapy, 2020, 37 : 4754 - 4754
  • [42] A PHASE 1, OPEN-LABEL, FIXED-SEQUENCE, CROSSOVER STUDY TO EVALUATE THE INTERACTION OF MULTIPLE-DOSE ODEVIXIBAT WITH THE PHARMACOKINETICS OF SINGLE-DOSE COMBINED ORAL CONTRACEPTIVE STEROIDS IN HEALTHY FEMALE PARTICIPANTS
    Mazuir, Florent
    Ordonez, Claudia
    Wallefors, Terese
    Zhu, Judy
    Lindstrom, Erik
    HEPATOLOGY, 2024, 80 : S1773 - S1774
  • [43] Pharmacokinetics and bioequivalence of Ezetimibe tablet versus Ezetrol®:an open-label, randomized, two-sequence crossover study in healthy Chinese subjects
    Sun, Feifei
    Liu, Yanping
    Li, Ting
    Lin, Pingping
    Jiang, Xin
    Li, Xin
    Wang, Chenjing
    Gao, Xiaomeng
    Ma, Yaping
    Fu, Yao
    Cao, Yu
    BMC PHARMACOLOGY & TOXICOLOGY, 2023, 24 (01):
  • [44] Pharmacokinetics and bioequivalence of Ezetimibe tablet versus Ezetrol®:an open-label, randomized, two-sequence crossover study in healthy Chinese subjects
    Feifei Sun
    Yanping Liu
    Ting Li
    Pingping Lin
    Xin Jiang
    Xin Li
    Chenjing Wang
    Xiaomeng Gao
    Yaping Ma
    Yao Fu
    Yu Cao
    BMC Pharmacology and Toxicology, 24
  • [45] Correction to: Physiologically based pharmacokinetic modelling to predict the clinical effect of CYP3A inhibitors/inducers on esaxerenone pharmacokinetics in healthy subjects and subjects with hepatic impairment
    Akiko Watanabe
    Tomoko Ishizuka
    Makiko Yamada
    Yoshiyuki Igawa
    Takako Shimizu
    Hitoshi Ishizuka
    European Journal of Clinical Pharmacology, 2022, 78 : 75 - 75
  • [46] A Phase 1, Open-Label Study of the Effect of Albuterol or Fluticasone on the Pharmacokinetics of Inhaled Technosphere® Insulin Inhalation Powder in Healthy Subjects
    Baughman, Robert A.
    Cassidy, James P.
    Amin, Nikhil
    Hompesch, Marcus
    Marino, Mark T.
    Haworth, Pamela C.
    Richardson, Peter C.
    DIABETES, 2010, 59 : A143 - A143
  • [47] A Phase 1, Open-Label Study to Evaluate the Effect of Food and Concomitant Itraconazole Administration on the Pharmacokinetics of AMG 986 in Healthy Subjects
    Trivedi, Ashit
    Mather, Omar
    Vega, Silvia
    Hutton, Shauna
    Hellawell, Jennifer
    Lee, Edward
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2022, 11 (07): : 849 - 856
  • [48] A Phase I, Open-label, Single-Dose Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of AMG 986 in Healthy Japanese Subjects
    Trivedi, Ashit
    Mather, Omar
    Vega, Silvia
    Hutton, Shauna
    Hellawell, Jennifer
    Lee, Edward
    DRUGS IN R&D, 2022, 22 (02) : 141 - 146
  • [49] Evaluation of the Pharmacokinetics and Safety of AMG 986 Tablet and Capsule Formulations in Healthy Adult Subjects: A Phase I, Open-Label, Randomized Study
    Ashit Trivedi
    Y.-H. Kiang
    Robert E. Saw
    Guilong Charles Cheng
    Omar Mather
    Silvia Vega
    Jennifer Hellawell
    Edward Lee
    Drugs in R&D, 2022, 22 : 147 - 154
  • [50] Evaluation of the Pharmacokinetics and Safety of AMG 986 Tablet and Capsule Formulations in Healthy Adult Subjects: A Phase I, Open-Label, Randomized Study
    Trivedi, Ashit
    Kiang, Y. -H.
    Saw, Robert E.
    Cheng, Guilong Charles
    Mather, Omar
    Vega, Silvia
    Hellawell, Jennifer
    Lee, Edward
    DRUGS IN R&D, 2022, 22 (02) : 147 - 154
12345